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Abstract
This study investigated the anticonvulsant activity of Citrullus colocynthis fruit extract used traditionally in the treatment of convulsion.
Albino mice were pretreated with extract in different doses (10, 25, 50, and 100 mg/kg), prior to injection of pentylenetetrazole.
Animals received pretreatments with naloxone and flumazenil to further clarify the mechanisms of anticonvulsant action. The total
flavonoid content ofCitrullus colocynthis extractwas also determined.Citrullus colocynthis hydroalcoholic extractwith doses 25 and 50
mg/kg prolonged the onset of seizures and decreased the duration compared with control group. Pretreatment by flumazenil could
inhibit the effect of Citrullus colocynthis on latency of seizure to some extent and administration of naloxone significantly inhibited
changes in latency and duration of seizure produced by Citrullus colocynthis. This study showed that Citrullus colocynthis has significant
anticonvulsant effect in pentylenetetrazole-induced seizures inmice, and these effectsmay be related to its effect on g-aminobutyric
acid-ergic and opioid systems. These results confirmed the traditional use of Citrullus colocynthis in Iranian traditional medicine.
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Epilepsy is one of the most common neurological disorders
that affects about 50 million people worldwide.1 There is an
increasing need to explore new natural medicines due to difficul-
ties of classic treatments, that is, inefficiency or side effects and
chronic toxicity of drugs.2 So, there is an increasing interest to use
natural remedies that could be effective alternatives. There are
some herbs in Iranian traditional medicine for treatment of epi-
lepsy.3 Citrullus colocynthis (L.) Schrad. (Cucurbitaceae),
Knownas bitter apple orwild gourd, is one of themedicinal plants
recommended for treatment of seizure.4 Other pharmacological
activities have been also mentioned in Iranian traditional medi-
cine suchaspurgative, anti-inflammatory, antidiabetic, analgesic,
hypolipidemic, antioxidant, abortifacient, and antiepileptic.4,5
This plant grows in south, center, and east of Iran. The main
medicinal part of the plant is the fruit pulp, and it is better to use
the fruit pulp for extraction. So far, different biological activities
were reported from Citrullus colocynthis.4 Fruits of Citrullus
colocynthis showed analgesic, purgative, anti-inflammatory,
antioxidant, antidiabetic, and hypolipidemic activities.6-11 Sev-
eral bioactive compounds of Citrullus colocynthis fruit have
been reported in the literature. They are grouped as glycosides,
flavonoids, alkaloids, carbohydrates, fatty acids, and essential
oils.12-14 Cucurbitacins have been reported as themain chemical
constituents of Citrullus colocynthis fruits.
According to our investigations, the antiepileptic effect of
Citrullus colocynthis has not been studied so far. Following our
previous studies on Iranianmedicinal plant,3 in the present study,
anticonvulsant activity and possible mechanisms of action of
Citrullus colocynthis extract were studied in pentylenetetrazole-
induced seizures in mice for the first time.
Methods
Plants Material
Citrullus colocynthis fruits were purchased from a local herbal mar-
ket in Tehran, Iran and its authenticity was approved by Dr G.
Amin, member of the School of Pharmacy, Tehran University of
Medical Sciences, Tehran, Iran (No. PmP-640). The seeds were
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removed from fruit pulps and the pulps were dried. Hydroalcoholic
extract (70:30 alcohol:water) of fruit pulps was prepared by macera-
tion method (3 times) and the extract was dried by rotary evapora-
tor. The extract was dissolved in normal saline when used in the
animal study.
Total Flavonoid Content
The total flavonoid content of Citrullus colocynthis extract was deter-
mined using AlCl3 reagent.
15 Briefly, 2.5 mL of each sample (and/or
quercetin as the standard), previously dissolved in 90% ethanol, was
mixed with 2.5 mL of a 2% AlCl3 solution in 90% ethanol. After
40 minutes, the absorbance of the yellow color produced was mea-
sured at 425 nm. The total flavonoid content (as mmicrograms [mg]
quercetin equivalents/milligram [mg] of sample) for the sample was
calculated on the basis of a linear calibration curve obtained using
quercetin (y ¼ 0.0169x þ 0.3526, r2 ¼ 0.995).
Animals
Male albino mice (n¼ 36, weight 25-30 g) were housed in animal unit
of Iran University of Medical Sciences under standard laboratory con-
ditions (temperature 23C + 2C) with 12-hour dark and 12-hour
light cycle. The animals were fed with standard dry pellet diet and tap
water ad libitum. All possible steps were taken to avoid animal suffer-
ing at each stage of the experiment.
Ethics
This study was performed according to the guidelines of the US
National Institutes of Health (NIH publication no. 85.23, revised
1985) guides for the care of lab animals.
Chemicals
Pentylenetetrazole (Sigma, St Louis, MO, USA) and diazepam
(Darupakhsh, Iran), naloxone (Sigma) and flumazenil (Darupakhsh,
Iran) were purchased from commercial sources.
Experimental Studies
Anticonvulsant Activity. Seizures were induced in mice with standard
agent, pentylenetetrazole (60 mg/kg, intraperitoneally).16,17 The ani-
mals were divided randomly into 6 groups (n ¼ 6). Group I served as
a control and received normal saline (10 mL/kg, intraperitoneally),
group II was treated with diazepam (1 mg/kg, intraperitoneally),
as positive control group and groups III to VI, respectively, received
the extract in doses of 10, 25, 50, and100 mg/kg, intraperitoneally.
After 30 minutes, all groups received the chemoconvulsant agent,
pentylenetetrazole. Following induction of convulsions in mice with
intraperitoneal injections of pentylenetetrazole, the animals were
observed for 30 minutes for signs of neurological deficits, particu-
larly hindlimb tonic convulsions. Hindlimb tonic extensions of the
mice were regarded as seizures. Animals without any convulsion
after 30 minutes were considered as protected. The latency and dura-
tion of seizures were recorded for 30 minutes after injection of
pentylenetetrazole in the unprotected animals. Also, the animals
were observed for mortality for 24 hours after pentylenetetrazole
administration.
Evaluation of the Effect of Flumazenil on the Anticonvulsant Activity
of Citrullus colocynthis Extract. The effect of flumazenil, a benzo-
diazepine receptor antagonist, on the anticonvulsant activity of Citrul-
lus colocynthis was studied in order to investigate the probable
involvement of benzodiazepine receptors.18,19 Animals were divided
randomly into 6 groups (n ¼ 6). In the first group, mice were given
flumazenil (2 mg/kg) 5 minutes before the administration of Citrullus
colocynthis (50 mg/kg, intraperitoneally) and 35 minutes before the
injection of pentylenetetrazole. In the second group, the animals
received flumazenil (2 mg/kg) 5 minutes before the administration
of diazepam (1 mg/kg). Also, 3 groups were injected diazepam
(1 mg/kg, intraperitoneally), flumazenil (2 mg/kg), and normal saline
30 minutes before the administration of pentylenetetrazole (60 mg/kg,
intraperitoneally) respectively.18,19 Then latency and duration of con-
vulsion in 30 minutes after injection of pentylenetetrazole, protection
percentage and also mortality rate during the first 24 hours were
recorded. The anticonvulsant activity of Citrullus colocynthis and dia-
zepam in mice pretreated with flumazenil was assessed and compared
with normal saline (10 mL/kg), flumazenil (2 mg/kg), diazepam
(1 mg/kg), and Citrullus colocynthis (50 mg/kg, intraperitoneally)
treated animals.
Evaluation of the Effect of Naloxone on the Anticonvulsant Activity of
Citrullus colocynthis Extract. Animals were divided to 4 groups
randomly (n ¼ 6) for further investigation of probable modulatory
effect of opioid receptors on the anticonvulsant activity of Citrullus
colocynthis.19,20 Naloxone, an opioid receptor antagonist, was adminis-
tered (5 mg/kg, intraperitoneally) 5 minutes beforeCitrullus colocynthis
(50 mg/kg, intraperitoneally) and 35 minutes before the injection of
pentylenetetrazole to animals.20,21 The anticonvulsant activity ofCitrul-
lus colocynthis in groups pretreated with naloxone was compared with
animals pretreated only with Citrullus colocynthis (50 mg/kg, intraper-
itoneally), naloxone (5 mg/kg), and normal saline (10 mL/kg).
Statistical Analysis
The results are reported as mean + standard error of the mean and
tested with 1-way analysis of variance followed by the multiple com-




Total flavonoid content of the Citrullus colocynthis hydroalco-
holic extract as micrograms quercetin equivalents/milligram of
sample was 10.7 + 0.1 mg/g (mean + standard error of the
mean, n ¼ 3).
Anticonvulsant Activity on Pentylenetetrazole-Induced
Seizure
Injection of the Citrullus colocynthis extract (25 and 50 mg/kg)
prolonged significantly the onset of seizure (P < .05 and
P < .01, respectively) and decreased the duration of seizures
(P < .01) compared with the saline group. Also, Citrullus colo-
cynthis extract (10 and 100 mg/kg) decreased duration of sei-
zures significantly (P < .05), but had no significant effect on
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latency. In addition, Citrullus colocynthis extract (25 and
50 mg/kg) exhibited protection against seizure in 16.66% of
animals and reduced mortality compared with the control
group. Diazepam (1 mg/kg) protected 100% of mice from
pentylenetetrazole-induced seizure and mortality (Table 1).
The Effect of Flumazenil on the Anticonvulsant Activity of
Citrullus colocynthis Extract
Administration of flumazenil (2 mg/kg) 5 minutes before
Citrullus colocynthis hydroalcoholic extract (50 mg/kg) and
35 minutes before the injection of pentylenetetrazole, resulted
in inhibition of prolonged latency produced by extract solution
(P < .01); but had no significant effect on duration of seizure.
So, flumazenil reversed the action of Citrullus colocynthis
extract to some extent. Also, flumazenil could reverse the antic-
onvulsant activity of diazepam (Table 2).
The Effect of Naloxone on the Anticonvulsant Activity of
Citrullus colocynthis Extract
In the group receiving naloxone (5 mg/kg) before Citrullus
colocynthis extract (50 mg/kg) and pentylenetetrazole, the
effect ofCitrullus colocynthis extract was reversed in prolonging
seizure latency (P < .01) and duration of seizure compared with
the group treated with Citrullus colocynthis extract (50 mg/kg;
Table 3).
Discussion
According to complexity in treatment of epilepsy with modern
antiepileptic drugs, interest in discovering new alternative
medicine from natural sources has increased.2 In Iranian tradi-
tional medicine, some herbs, such as Citrullus colocynthis,
have been recommended for treatment of epilepsy.4
Table 2. Effect of Flumazenil on the Anticonvulsant Activity of Citrullus colocynthis Extract in Pentylenetetrazole-Induced Convulsion in Mice.a
Treatment Group % Protection (30 min) Seizure Latency (s) Seizure Duration (s) Mortality (24 h)
PTZ þ NS (10 mL/kg) 0 83.75 + 12.36 31.60 + 3.58 4/6
Flumazenil (2 mg/kg) 0 80.50 + 5.23 25.83 + 2.12 3/6
Diazepam (1 mg/kg) 100 — — 0/6
Diazepam þ flumazenil 0 116 + 10.65 29.33 + 2.28 2/6
Citrullus colocynthis (50 mg/kg) 16.66 912.0 + 205.2*** 11.95 + 3.48*** 0/6
Citrullus colocynthis (50 mg/kg) þ Flumazenil 0 294.4 + 75.8** 10.00 + 3.06*** 3/6
Abbrevations: NS, normal saline; PTZ, pentylenetetrazole.
aData are expressed as mean + standard error of the mean (n ¼ 6).
**P < .01 compared with the Citrullus colocynthis (50 mg/kg) group. ***P < .001 compared with the control group.
Table 3. Effect of Naloxone on the Anticonvulsant Activity of Citrullus colocynthis in Pentylenetetrazole-Induced Convulsion in Mice.a
Treatment Group % Protection (30 min) Seizure Latency (s) Seizure Duration (s) Mortality (24 h)
PTZ þ NS (10 mL/kg) 0 83.75 + 12.36 31.60 + 3.58 4/6
Naloxone (5 mg/kg) 0 50.33 + 4.34 48.50 + 3.88 4/6
Citrullus colocynthis (50 mg/kg) 16.66 912.0 + 205.2*** 11.95 + 3.48* 0/6
Citrullus colocynthisþ naloxone 0 129.9 + 28.26** 29.33 + 11.10 3/6
Abbrevations: NS, normal saline; PTZ, pentylenetetrazole.
aData are expressed as mean + standard error of the mean (n ¼ 6).
*P < .005, ***P < .001 compared with the control group. **P < .01 compared with the Citrullus colocynthis (50 mg/kg) group.
Table 1. Effect of Citrullus colocynthis Extract on Pentylenetetrazole-Induced Seizure in Mice.a
Treatment Group % Protection (30 min) Seizure Latency (s) Seizure Duration (s) Mortality (24 h)
PTZ þ NS (10 mL/kg) 0 83.75 + 12.36 31.60 + 3.58 4/6
PTZ þ diazepam (1 mg/kg) 100 — — 0/6
PTZ þ Citrullus colocynthis (10 mg/kg) 0 210.7 + 36.40 18.34 + 5.06* 2/6
PTZ þ Citrullus colocynthis (25 mg/kg) 16.66 727.7 + 242.0* 12.28 + 3.55** 1/6
PTZ þ Citrullus colocynthis (50 mg/kg) 16.66 912.0 + 205.2** 11.95 + 3.48** 0/6
PTZ þ Citrullus colocynthis (100 mg/kg) 0 320.4 + 60.45 17.51 + 3.85* 2/6
Abbrevations: NS, normal saline; PTZ, pentylenetetrazole.
aData are expressed as mean + standard error of the mean (n ¼ 6).
*P < .05, **P < .01 compared with the control group.
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Citrullus colocynthis is used in different parts of the world to
treat different diseases, including diabetes, some gastrointest-
inal disorders, leprosy, asthma, bronchitis, jaundice, joint pain,
cancer, and mastitis as well as common cold, cough, toothache,
and wounds.4,22-24
Although Citrullus colocynthis fruit has been used for many
years, reports on systematic toxicity and safety evaluation are
rare. Investigating the acute toxicity and histopathological
effects of saponin (extracted from whole plant of Citrullus
colocynthis) on mice, Diwan et al25 reported the median lethal
dose to be 200 mg/kg.
Some traditional use of Citrullus colocynthis was confirmed
in modern scientific studies. But antiepileptic effect of the fruit
pulp of Citrullus colocynthis has not been studied so far. So, in
this study, anticonvulsant activity and possible mechanisms of
action of Citrullus colocynthis were studied in an animal model
for the first time.
The results of this study indicated that Citrullus colocynthis
pulp extract demonstrated a statistically significant reduction in
the seizures duration and increase in latency period of seizures
induced by pentylenetetrazole in mice. This effect increased
dose dependently at doses of 10, 25, and 50mg/kg, but decreased
at the dose of 100 mg/kg, which may be due to its toxicity.
The main action of the pentylenetetrazole-induced seizure is
reducing g-aminobutyric acid (GABA) level in the cortex.
GABA has been reported as the predominant inhibitory neu-
rotransmitter in the central nervous system of mammals and
has been implicated in convulsions as it mediates the inhibi-
tion of neuronal responsiveness and activity by increasing the
chloride-ion conductance through the opening of the chloride-
ion channel.16,26 The findings of the present study tend to
suggest that Citrullus colocynthis pulp extract might have
delayed the occurrence of pentylenetetrazole-induced seizure
and reduced its duration by acting on GABAergic system.
Naloxone decreased the prolongation of seizure latency
induced by Citrullus colocynthis pulp extract and it also antag-
onized the effect of Citrullus colocynthis pulp extract on
decreasing the duration of seizures in the pentylenetetrazole
model. So, the anticonvulsant effect of Citrullus colocynthis
is blocked by an antagonist of opioid receptor, and therefore
this effect of Citrullus colocynthis seems to be related to opioid
receptor activation.
Administration of flumazenil before Citrullus colocynthis
led to decrease in latency of seizures in some extent compared
with Citrullus colocynthis group. This shows that flumazenil
antagonizes the effect of Citrullus colocynthis on latency time
seizures in the pentylenetetrazole model, so anticonvulsant
effect of Citrullus colocynthis is probably due to activation
of benzodiazepine receptors to some extent. Since opioid and
benzodiazepines receptors both are present on GABA receptor
complex, it can be deduced that the effect of Citrullus colo-
cynthis might be on different receptors modulating the activity
of GABA receptor complex. In a study by Meena and Patni,27
flavonoid quercetin was isolated fromCitrullus colocynthis and
in this study total flavonoid content of Citrullus colocynthus
extract has been determined according to quercetin. Since
flavonoids are the most potent compounds in plants, it is pos-
sible that antiepileptic effect of Citrullus colocynthis is due
to its flavonoid components. Although further studies are nec-
essary to confirm this claim.
In conclusion, the results obtained from this work suggest
that Citrullus colocynthis pulp extract has anticonvulsant activ-
ity and this supports the use of the plant traditionally in the
treatment of convulsion. This observed activity of the plant
extract on the pentylenetetrazole-induced seizures supports the
involvement of the GABA pathway. Further investigation is
required to find out which compounds may be responsible for
the observed activity and determine their specific mechanism
of action.
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